# Study of NS-9 in Patients With Liver Metastases

> **NCT00094003** · PHASE1 · COMPLETED · sponsor: **NS Pharma, Inc.** · enrollment: 20 (—)

## Conditions studied

- Liver Neoplasms
- Neoplasm Metastasis
- Local Neoplasm Recurrences

## Interventions

- **DRUG:** NS-9 [Poly I: Poly C]

## Key facts

- **NCT ID:** NCT00094003
- **Lead sponsor:** NS Pharma, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-09
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 20 (—)
- **Last updated:** 2005-11-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00094003

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00094003, "Study of NS-9 in Patients With Liver Metastases". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00094003. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*